90022437 - IMGT IMAGE GUIDED THERAPY

Information

  • Trademark
  • 90022437
  • Serial Number
    90022437
  • Registration Number
    6542241
  • Filing Date
    June 26, 2020
    4 years ago
  • Registration Date
    November 02, 2021
    3 years ago
  • Transaction Date
    November 02, 2021
    3 years ago
  • Status Date
    November 02, 2021
    3 years ago
  • Published for Opposition Date
    August 17, 2021
    3 years ago
  • Location Date
    November 02, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    VAGHANI, MAYUR C
  • Attorney Docket Number
    6375-0031TM
    Attorney Name
    Yoon S. Ham
    Law Office Assigned Location Code
    N60
  • Owners
Mark Drawing Code
3000
Mark Identification
IMGT IMAGE GUIDED THERAPY
Case File Statements
  • CC0000: The color(s) blue and light blue is/are claimed as a feature of the mark.
  • D10000: "IMAGE GUIDED THERAPY"
  • DM0000: The mark consists of a bent molecule feature composed of a larger light blue orb with blue shading connected with two smaller light blue orbs with blue shading, next to the stylized wording of "IMGT" in blue, over the stylized wording of "IMage Guided Therapy" where the letters, "IM" are in blue, "age" are in light blue, "G" are in blue, "uided" are in light blue, "T" are in blue, and "herapy" are in light blue.
  • GS0051: Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting peripheral nervous system; Enzymes for medical purposes; Pharmaceutical preparations acting on the central nervous system; Antibiotic preparations; Chemotherapeutics; Veterinary vaccines; Vaccines; Chemical reagents for medical or veterinary purposes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of CNS disorders; Pharmaceutical preparations for the treatment of peripheral vascular or neurologic disease; Pharmaceutical preparations for the treatment of lesions; Pharmaceutical preparations for reliving pain; Pharmaceutical preparations for activating drug delivery; Nutraceuticals for use as a dietary supplement for promoting digestion; Anti-cancer preparations
  • GS0101: Medical apparatus, namely, medical ultrasound apparatus; Medical apparatus, namely, ultrasound diagnostic apparatus; Medical instruments for use in general surgery; Medical apparatus for treating cancer; Medical apparatus for treating cancer by using ultrasound; Medical apparatus for treating CNS disorders; Medical apparatus for treating CNS disorders by using ultrasound; Medical apparatus for treating peripheral vascular or neurologic disease; Medical apparatus for treating peripheral vascular or neurologic disease by using ultrasound; Medical apparatus for treating dermatological disease by using ultrasound; Medical apparatus for treating dermatological disease; Medical apparatus for treatment of lesions; Medical apparatus for treatment of lesions through hyperthermia caused by using ultrasound; Medical apparatus for relieving pain; Medical apparatus for relieving pain by using ultrasound; Medical apparatus for activating drug delivery; Medical apparatus for activating drug delivery by using ultrasound; Syringes for medical purposes and for injections; Medical apparatus for detecting cancer; Dental instruments, namely, picks, burrs, mirrors, prophy angles, oral irrigators, crown and bridge removers; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Diagnostic apparatus for the detection of periodontal disease; Diagnostic apparatus for the detection of cancer; Medical diagnostic apparatus for detecting cancer; Injection device for pharmaceuticals; Syringes for medical purposes; Syringes for injection of medical substances; Hypodermic syringes
  • GS0421: Drug discovery services; Biotechnology research; Biomedical research services; Laboratory research in the field of biology; Providing information on the subject of scientific research in the field of Biochemistry and biotechnology; Biological research; Bacteriological research; Pharmaceutical research and development; Research on the subject of pharmaceuticals; Clinical research in the field of medicines for detection and treatment of cancer; Conducting clinical trials for others in the field of medicines for detection and treatment of cancer; Medical research services; Scientific research for medical purposes in the field of cancer; Testing of pharmaceuticals; Testing of materials; Chemical research and analysis; Chemical research services
Case File Event Statements
  • 11/2/2021 - 3 years ago
    23 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 8/17/2021 - 3 years ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/17/2021 - 3 years ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/28/2021 - 3 years ago
    20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/12/2021 - 3 years ago
    19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/15/2021 - 3 years ago
    18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/15/2021 - 3 years ago
    17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/7/2021 - 3 years ago
    16 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 3/22/2021 - 3 years ago
    15 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 3/22/2021 - 3 years ago
    14 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 3/22/2021 - 3 years ago
    13 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 3/19/2021 - 3 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/19/2021 - 3 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/19/2021 - 3 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/2/2020 - 4 years ago
    9 - COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED Type: CEPE
  • 10/2/2020 - 4 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 10/2/2020 - 4 years ago
    7 - NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Type: GEAN
  • 10/2/2020 - 4 years ago
    6 - EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Type: GEAP
  • 10/2/2020 - 4 years ago
    5 - EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED Type: CPEA
  • 9/29/2020 - 4 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/24/2020 - 4 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 7/23/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 6/30/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP